Abstract: Provided is an automatic train tracking method, including: acquiring and displaying a real-time video image captured by a current image capture device (S101); wherein a plurality of image capture devices are sequentially arranged beforehand in a traveling direction of a train on a traveling route; detecting, based on the real-time video image, whether the train currently enters a capture range of the current image capture device (S102); taking, when it is detected that the train enters the capture range of the current image capture device, a next image capture device as the current image capture device (S103), returning to the step of acquiring and displaying a real-time video image captured by the current image capture device (S101), wherein the next image capture device is an image capture device adjacent to the current image capture device in the traveling direction. Further disclosed is an automatic train tracking system.

Abstract: Nitrification inhibitors and uses of same to prevent nitrate leaching or nitrous oxide emissions as well as increase pasture or crop production. The nitrification inhibitors and formulations including same may be used for direct or indirect application to soil or pasture.

Abstract: The use of ferric sulphate or polyferric sulphate to treat liquid animal effluent to reduce methane emissions therefrom.

Abstract: Nitrification inhibitors and uses of same to prevent nitrate leaching or nitrous oxide emissions as well as increase pasture or crop production. The nitrification inhibitors and formulations including same may be used for direct or indirect application to soil or pasture.

Abstract: Nitrification inhibitors and uses of same to prevent nitrate leaching or nitrous oxide emissions as well as increase pasture or crop production. The nitrification inhibitors and formulations including same may be used for direct or indirect application to soil or pasture.

Abstract: A hybrid power transmission for a hybrid power vehicle comprising a motor, a motor shaft connected to the motor, a transmission input shaft connected to an internal combustion engine, and a transmission output shaft is provided. The transmission input shaft and the motor shaft are arranged coaxially, and the motor shaft is designed as a hollow shaft. A first gear is disposed on the motor shaft in a sleeved manner, a third gear and a fifth gear are disposed on the transmission input shaft in a torsion-proof manner, a first synchronizer is disposed between the first gear and the third gear. A second gear is disposed on the transmission output shaft in a torsion-proof manner, the second gear meshing with the first gear, a fourth gear and a sixth gear are disposed on the transmission output shaft in a sleeved manner, the fourth gear meshing with the third gear, the sixth gear meshing with the fifth gear, and a second synchronizer is disposed between the fourth gear and the sixth gear.

Abstract: Provided herein are compositions and methods for their administration as therapeutic agents. In particular, provided herein are compositions and their use for the administration of antiviral peptide therapeutics.

Abstract: Provided is a pharmaceutical composition comprising a solution comprised of synthetic peptide in a final concentration of not less than 70 mg/ml in admixture with a polyol; wherein the synthetic peptide is an HIV fusion inhibitor, and wherein the polyol is in a final concentration of no less than 5 weight % and no more than 75 weight % of the pharmaceutical composition. Also provided is a synthetic peptide-containing pharmaceutical composition as a unit dose comprising an aqueous formulation comprised of synthetic peptide in a final concentration of not less than 70 mg/ml in admixture with a polyol; wherein the synthetic peptide is an HIV fusion inhibitor, and wherein the polyol is in a final concentration of no less than 5 weight % and no more than 75 weight % of the pharmaceutical composition. Further provided is a method of treating HIV infection by administering to an HIV-infected individual a pharmaceutical composition according to the present invention.

Abstract: A nitrification inhibitor treatment used as a soil mangement tool on grazed pasture soils. The treatment includes the application of nitrification inhibitors in solution form and/or line particle suspension form and/or in crystalline form to treat the whole area of grazed pasture soils to: reduce nitrate leaching; reduce nitrous oxide emissions; reduce postassium, calcium and magnesium leaching; and increase pasture production in both the animal urine patch areas and non-urine patch areas. The nitrification inhibitors can be applied in conjunction with irrigation water, by a spray vehicle or in a similar way to the application of agricultural chemicals.

Abstract: Provided is a pharmaceutical composition comprising a solution comprised of synthetic peptide in a final concentration of not less than 70 mg/ml in admixture with a polyol; wherein the synthetic peptide is an HIV fusion inhibitor, and wherein the polyol is in a final concentration of no less than 5 weight % and no more than 75 weight % of the pharmaceutical composition. Also provided is a synthetic peptide-containing pharmaceutical composition as a unit dose comprising an aqueous formulation comprised of synthetic peptide in a final concentration of not less than 70 mg/ml in admixture with a polyol; wherein the synthetic peptide is an HIV fusion inhibitor, and wherein the polyol is in a final concentration of no less than 5 weight % and no more than 75 weight % of the pharmaceutical composition. Further provided is a method of treating HIV infection by administering to an HIV-infected individual a pharmaceutical composition according to the present invention.

Abstract: Methods relating to the field of biochemistry and more specifically relating to microparticles for use in diagnostics, therapeutics, and research are provided.

Abstract: Microparticles formed by mixing a macromolecule with a polymer at a pH near the isoelectric point of the macromolecule and incubating the mixture in the presence of an energy source for a predetermined length of time. The microparticles are composed of homogeneously distributed, intertwined macromolecule and polymer. Each microparticle allows aqueous fluids to enter and allows solubilized macromolecule and polymer to exit the microparticle and may be formulated to provide a sustained release of macromolecule and polymer from the interior of the microparticle when placed in an appropriate aqueous medium, such as under physiological conditions. Methods of production and methods of use for research, diagnostics and therapeutics are provided.

Abstract: Microparticles formed by mixing a macromolecule with a polymer at a pH near the isoelectric point of the macromolecule and incubating the mixture in the presence of an energy source for a predetermined length of time. The microparticles are composed of homogeneously distributed, intertwined macromolecule and polymer. Each microparticle allows aqueous fluids to enter and allows solubilized macromolecule and polymer to exit the microparticle and may be formulated to provide a sustained release of macromolecule and polymer from the interior of the microparticle when placed in an appropriate aqueous medium, such as under physiological conditions. Methods of production and methods of use for research, diagnostics and therapeutics are provided.

Abstract: Microparticles formed by mixing a macromolecule with a polymer at a pH near the isoelectric point of the macromolecule and incubating the mixture in the presence of an energy source for a predetermined length of time. The microparticles are composed of homogeneously distributed, intertwined macromolecule and polymer. Each microparticle allows aqueous fluids to enter and allows solubilized macromolecule and polymer to exit the microparticle and may be formulated to provide a sustained release of macromolecule and polymer from the interior of the microparticle when placed in an appropriate aqueous medium, such as under physiological conditions. Methods of production and methods of use for research, diagnostics and therapeutics are provided.

Abstract: A method and kit for making a polysaccharide-protein Schiff base conjugate. A polysaccharide is oxidized with an oxidizing agent and combined with a protein in the presence of a macromolecular crowding agent to form a Schiff base. Preferably, the macromolecular crowding agent is a soluble linear polymer selected from the group consisting of polyvinylpyrrolidone, polyethylene glycol, dextran, nonylphenol-ethoxylates, polyvinyl alcohol, and mixtures thereof. Most preferably, the macromolecular crowding agent is a mixture of polyvinylpyrrolidone and polyethylene glycol. The microparticles or substantially dissolved microparticles are immunogenic and are useful for inducing an immune response when administered to humans or animals.